Skip to content

MEG language and memory mapping: a comparison with WADA.

MEG language and memory mapping: a comparison with WADA.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24624
Enrollment
10
Registered
2009-06-30
Start date
2009-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

candidates for brain surgery with epilepsy and/or brain tumours.

Interventions

Language and memory areas will be localised using Magnetoencephalography (MEG). The effectiveness of the protocol will be evaluated by comparison with Wada (intracarotid sodium amobarbital procedure)

Sponsors

VUmc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 85; 2. Has had, or will undergo, a Wada test; 3. Will undergo a MEG and MRI scan as part of a pre-surgical evaluation; 4. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Unable to undergo an MRI scan; 2. Insufficient mastery of the Dutch language; 3. Inability to communicate adequately.

Design outcomes

Primary

MeasureTime frame
The raw recorded MEG signals will be post-processed according to standard procedures, and artefact-free epochs will be selected by an experienced investigator. These epochs are then used to localise underlying neuronal activity using an MEG beamformer, in combination with the patient’s anatomical MRI. A lateralisation index will be computed on the basis of the reconstructed task-related neuronal power changes. In addition, a lateralisation index will be obtained from the Wada procedure by experienced neuropsychologists who are blinded to the MEG results.

Secondary

MeasureTime frame
The lateralisation index computed on the basis of MEG and Wada, respectively, will be compared.

Contacts

Public ContactAlexandra M.E. Linger

Klinische Neurofysiologie/Magneto-encefalografie VU medisch centrum Receptie C PK -1 Z kamer 150 de Boelelaan 1118

alexandra.linger@vumc.nl+ 31 (0) 20 444 0677

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)